Oral corticosteroid prescription in asthma: Swiss situation

C. Schuoler (Baar, Switzerland), J. Leuppi (Liestal, Switzerland), T. Rothe (Chur, Switzerland), A. Jochmann (Basel, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Steurer-Stey (Zürich, Switzerland), F. Charbonnier (Geneva, Switzerland), H. Duchna (Davos, Switzerland), P. Bridevaux (Sion, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), C. Leuenberger (Baar, Switzerland), G. Pendl (Baar, Switzerland)

Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Session: Clinical and laboratory pharmacology in asthma
Session type: E-poster session
Number: 1405
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Schuoler (Baar, Switzerland), J. Leuppi (Liestal, Switzerland), T. Rothe (Chur, Switzerland), A. Jochmann (Basel, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Steurer-Stey (Zürich, Switzerland), F. Charbonnier (Geneva, Switzerland), H. Duchna (Davos, Switzerland), P. Bridevaux (Sion, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), C. Leuenberger (Baar, Switzerland), G. Pendl (Baar, Switzerland). Oral corticosteroid prescription in asthma: Swiss situation. 1405

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019



Oral corticosteroid use in Swedish and Finnish severe asthma patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Oral corticosteroids for asthma usually prescribed by non-specialists
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005



How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Year: 2020



Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019



Use of inhalation corticosteroids (ICS) in children with asthma in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 395s
Year: 2002

Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007


Once-daily inhaled corticosteroids in children with asthma: Not a simple solution for non-adherence
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022
Year: 2022



Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021

Is beta-agonist alone prescribed in case of uncontrolled asthma?
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1072-1074
Year: 2012